Home › Colorectal Cancer › Indiana › Fort Wayne
Colorectal Cancer clinical trials in Fort Wayne, IN
4 studies for Colorectal Cancer are looking for participants at sites in and around Fort Wayne (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RecruitingPhase 3
- Fort Wayne Medical Oncology & Hematology, Fort Wayne
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
RecruitingPhase 2/3
- Local Institution - 0638, Fort Wayne
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RecruitingPhase 3
- Clinical Study Site, Fort Wayne
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
RecruitingObservational study
- Parkview Cancer Institute, Fort Wayne
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY78 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Chicago, IL34 studies
Other studies in Fort Wayne
- Non-Small Cell Lung Cancer17 studies
- Ovarian Cancer8 studies
- Cancer (all types)7 studies
- Chronic Lymphocytic Leukemia7 studies
- Breast Cancer7 studies
- Lung Cancer6 studies
- Metastatic Cancer6 studies
- Endometrial Cancer5 studies
- Melanoma4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Triple-Negative Breast Cancer4 studies
- Multiple Myeloma4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.